Characterization of plasma β-secretase (BACE1) activity and soluble amyloid precursor proteins as potential biomarkers for Alzheimer's disease

Cerebrospinal Fluid Biomarkers in Mild Cognitive Impairment and Dementia

(2017) Joshua A. Sonnen et al.   JOURNAL OF ALZHEIMERS DISEASE

Plasma Amyloid-β Forms in Alzheimer's Disease and Non-Alzheimer's Disease Patients

(2017) Nathalie Le Bastard et al.   JOURNAL OF ALZHEIMERS DISEASE

BACE1 Activity in Cerebrospinal Fluid and Its Relation to Markers of AD Pathology

(2017) Sandra D. Mulder et al.   JOURNAL OF ALZHEIMERS DISEASE

Age and diagnostic performance of Alzheimer disease CSF biomarkers

(2012) N. Mattsson et al.   NEUROLOGY

Measurement of Aβ1-42 in cerebrospinal fluid is influenced by matrix effects

(2011) J. Randall Slemmon et al.   JOURNAL OF NEUROCHEMISTRY

Decrease in brain soluble amyloid precursor protein β (sAPPβ) in Alzheimer's disease cortex

(2011) Guoxin Wu et al.   JOURNAL OF NEUROSCIENCE RESEARCH

CSF soluble amyloid precursor proteins in the diagnosis of incipient Alzheimer disease

(2011) R. Perneczky et al.   NEUROLOGY

Increased Secreted Amyloid Precursor Protein-α (sAPPα) in Severe Autism: Proposal of a Specific, Anabolic Pathway and Putative Biomarker

(2011) Balmiki Ray et al.   PLoS One

Pharmacological applications of a novel neoepitope antibody to a modified amyloid precursor protein-derived beta-secretase product

(2011) Guoxin Wu et al.   Protein & Cell

Diagnosis-Independent Alzheimer Disease Biomarker Signature in Cognitively Normal Elderly People

(2010) Geert De Meyer   ARCHIVES OF NEUROLOGY

Acute  -Secretase Inhibition of Nonhuman Primate CNS Shifts Amyloid Precursor Protein (APP) Metabolism from Amyloid-  Production to Alternative APP Fragments without Amyloid-  Rebound

(2010) J. J. Cook et al.   JOURNAL OF NEUROSCIENCE

The use of PET in Alzheimer disease

(2010) Agneta Nordberg et al.   Nature Reviews Neurology

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

(2010) Kaj Blennow et al.   Nature Reviews Neurology

Is it time for biomarker-based diagnostic criteria for prodromal Alzheimer's disease?

(2010) Kaj Blennow et al.   Alzheimers Research & Therapy

Decreased cerebrospinal fluid Aβ42correlates with brain atrophy in cognitively normal elderly

(2009) Anne M. Fagan et al.   ANNALS OF NEUROLOGY

Pittsburgh Compound B Imaging and Prediction of Progression From Cognitive Normality to Symptomatic Alzheimer Disease

(2009) John C. Morris et al.   ARCHIVES OF NEUROLOGY

Elevated Cerebrospinal Fluid BACE1 Activity in Incipient Alzheimer Disease

(2008) Henrik Zetterberg et al.   ARCHIVES OF NEUROLOGY

Decrease in age-adjusted cerebrospinal fluid β-secretase activity in Alzheimer's subjects

(2008) Guoxin Wu et al.   CLINICAL BIOCHEMISTRY

First Demonstration of Cerebrospinal Fluid and Plasma A  Lowering with Oral Administration of a  -Site Amyloid Precursor Protein-Cleaving Enzyme 1 Inhibitor in Nonhuman Primates

(2008) S. Sankaranarayanan et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study

(2008) P Lewczuk et al.   MOLECULAR PSYCHIATRY

Evaluation of plasma Aβ40 and Aβ42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment

(2008) Oskar Hansson et al.   NEUROBIOLOGY OF AGING

Enhanced clearance of A  in brain by sustaining the plasmin proteolysis cascade

(2008) J. S. Jacobsen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

CSF amyloid-β 1-38 and 1-42 in FTD and AD: Biomarker performance critically depends on the detergent accessible fraction

(2008) Mirko Bibl et al.   Proteomics Clinical Applications

Solid-phase extraction enhances detection of beta-amyloid peptides in plasma and enables Aβ quantification following passive immunization with Aβ antibodies

(2007) Thomas A. Lanz et al.   JOURNAL OF NEUROSCIENCE METHODS